These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

584 related articles for article (PubMed ID: 28399348)

  • 1. Prevalence and Risk Factors of Osteoporosis in Postmenopausal Women with Type 2 Diabetes Mellitus.
    Raška I; Rašková M; Zikán V; Škrha J
    Cent Eur J Public Health; 2017 Mar; 25(1):3-10. PubMed ID: 28399348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In postmenopausal female subjects with type 2 diabetes mellitus, vertebral fractures are independently associated with cortisol secretion and sensitivity.
    Zhukouskaya VV; Eller-Vainicher C; Gaudio A; Cairoli E; Ulivieri FM; Palmieri S; Morelli V; Orsi E; Masserini B; Barbieri AM; Polledri E; Fustinoni S; Spada A; Fiore CE; Chiodini I
    J Clin Endocrinol Metab; 2015 Apr; 100(4):1417-25. PubMed ID: 25590217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The utility of lumbar spine trabecular bone score and femoral neck bone mineral density for identifying asymptomatic vertebral fractures in well-compensated type 2 diabetic patients.
    Zhukouskaya VV; Eller-Vainicher C; Gaudio A; Privitera F; Cairoli E; Ulivieri FM; Palmieri S; Morelli V; Grancini V; Orsi E; Masserini B; Spada AM; Fiore CE; Chiodini I
    Osteoporos Int; 2016 Jan; 27(1):49-56. PubMed ID: 26138582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppressed bone turnover was associated with increased osteoporotic fracture risks in non-obese postmenopausal Chinese women with type 2 diabetes mellitus.
    Jiajue R; Jiang Y; Wang O; Li M; Xing X; Cui L; Yin J; Xu L; Xia W
    Osteoporos Int; 2014 Aug; 25(8):1999-2005. PubMed ID: 24760246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sclerostin levels associated with inhibition of the Wnt/β-catenin signaling and reduced bone turnover in type 2 diabetes mellitus.
    Gaudio A; Privitera F; Battaglia K; Torrisi V; Sidoti MH; Pulvirenti I; Canzonieri E; Tringali G; Fiore CE
    J Clin Endocrinol Metab; 2012 Oct; 97(10):3744-50. PubMed ID: 22855334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of APOE Gene in Bone Mineral Density and Incidence of Bone Fractures in Brazilian Postmenopausal Women.
    Souza LS; Rochette NF; Pedrosa DF; Magnago RPL; Filho TBF; Vieira FLH; Fin IDCF; Eis SR; Graceli JB; Rangel LBA; Silva IV
    J Clin Densitom; 2018; 21(2):227-235. PubMed ID: 28784276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Status of bone strength and factors associated with vertebral fracture in postmenopausal women with type 2 diabetes.
    Chen FP; Kuo SF; Lin YC; Fan CM; Chen JF
    Menopause; 2019 Feb; 26(2):182-188. PubMed ID: 30130285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incident Fracture Risk in Type 2 Diabetic Postmenopausal Women in Mainland China: Peking Vertebral Fracture Study.
    Jiajue R; Qi X; Jiang Y; Wang Q; Wang W; Pei Y; Wang X; Huang W; Zheng X; Ning Z; Wang O; Li M; Xing X; Yu W; Xu L; Xia W
    Calcif Tissue Int; 2019 Nov; 105(5):466-475. PubMed ID: 31511960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postmenopausal Canarian women receiving oral glucocorticoids have an increased prevalence of vertebral fractures and low values of bone mineral density measured by quantitative computer tomography and dual X-ray absorptiometry, without significant changes in parathyroid hormone.
    Sosa M; Jódar E; Saavedra P; Navarro MC; Gómez de Tejada MJ; Martín A; Peña P; Gómez J
    Eur J Intern Med; 2008 Jan; 19(1):51-6. PubMed ID: 18206602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fracture risk assessment in postmenopausal women with diabetes: comparison between DeFRA and FRAX tools.
    Bonaccorsi G; Messina C; Cervellati C; Maietti E; Medini M; Rossini M; Massari L; Greco P
    Gynecol Endocrinol; 2018 May; 34(5):404-408. PubMed ID: 29172781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of serum sclerostin with bone mineral density, bone turnover, steroid and parathyroid hormones, and fracture risk in postmenopausal women: the OFELY study.
    Garnero P; Sornay-Rendu E; Munoz F; Borel O; Chapurlat RD
    Osteoporos Int; 2013 Feb; 24(2):489-94. PubMed ID: 22525978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased PTH levels accompanied by low bone formation are associated with vertebral fractures in postmenopausal women with type 2 diabetes.
    Yamamoto M; Yamaguchi T; Nawata K; Yamauchi M; Sugimoto T
    J Clin Endocrinol Metab; 2012 Apr; 97(4):1277-84. PubMed ID: 22337915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone Turnover Markers for Osteoporosis Status Assessment at Baseline in Postmenopausal Pakistani Females.
    Naeem ST; Hussain R; Raheem A; Siddiqui I; Ghani F; Khan AH
    J Coll Physicians Surg Pak; 2016 May; 26(5):408-12. PubMed ID: 27225148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between low C-peptide and fragility fractures in postmenopausal women without diabetes.
    Ferro Y; Russo C; Russo D; Gazzaruso C; Coppola A; Gallotti P; Zambianchi V; Fodaro M; Romeo S; Galliera E; Marazzi MG; Romanelli MMC; Giannini S; Pujia A; Montalcini T
    J Endocrinol Invest; 2017 Oct; 40(10):1091-1098. PubMed ID: 28401528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased serum sclerostin and decreased serum IGF-1 are associated with vertebral fractures among postmenopausal women with type-2 diabetes.
    Ardawi MS; Akhbar DH; Alshaikh A; Ahmed MM; Qari MH; Rouzi AA; Ali AY; Abdulrafee AA; Saeda MY
    Bone; 2013 Oct; 56(2):355-62. PubMed ID: 23845326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone mass loss is associated with systolic blood pressure in postmenopausal women with type 2 diabetes in Tibet: a retrospective cross-sectional study.
    Zhou L; Song J; Yang S; Meng S; Lv X; Yue J; Mina A; Puchi B; Geng Y; Yang L
    Osteoporos Int; 2017 May; 28(5):1693-1698. PubMed ID: 28154942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylation of bone SOST, its mRNA, and serum sclerostin levels correlate strongly with fracture risk in postmenopausal women.
    Reppe S; Noer A; Grimholt RM; Halldórsson BV; Medina-Gomez C; Gautvik VT; Olstad OK; Berg JP; Datta H; Estrada K; Hofman A; Uitterlinden AG; Rivadeneira F; Lyle R; Collas P; Gautvik KM
    J Bone Miner Res; 2015 Feb; 30(2):249-56. PubMed ID: 25155887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The value of osteopontin in the assessment of bone mineral density status in postmenopausal women.
    Fodor D; Bondor C; Albu A; Simon SP; Craciun A; Muntean L
    J Investig Med; 2013 Jan; 61(1):15-21. PubMed ID: 23117696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated sclerostin levels are associated with vertebral fractures in patients with type 2 diabetes mellitus.
    Yamamoto M; Yamauchi M; Sugimoto T
    J Clin Endocrinol Metab; 2013 Oct; 98(10):4030-7. PubMed ID: 23894157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High serum sclerostin predicts the occurrence of osteoporotic fractures in postmenopausal women: the Center of Excellence for Osteoporosis Research Study.
    Ardawi MS; Rouzi AA; Al-Sibiani SA; Al-Senani NS; Qari MH; Mousa SA
    J Bone Miner Res; 2012 Dec; 27(12):2592-602. PubMed ID: 22836717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.